{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:20:11Z","timestamp":1760080811433,"version":"3.37.3"},"reference-count":46,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 109-2321-B-002-032"],"award-info":[{"award-number":["MOST 109-2321-B-002-032"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.vaccine.2023.04.006","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T07:12:50Z","timestamp":1681110770000},"page":"3337-3346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Subunit vaccines with a saponin-based adjuvant boost humoral and cellular immunity to MERS coronavirus"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0783-2868","authenticated-orcid":false,"given":"Chi-Chieh","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Algaissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Chun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6507-0569","authenticated-orcid":false,"given":"Chun-Kai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0583-148X","authenticated-orcid":false,"given":"Jr-Shiuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9410-0429","authenticated-orcid":false,"given":"Yi-Shiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Hau","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0604-1471","authenticated-orcid":false,"given":"Yu-Chiuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Qing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bi\u2010Hung","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Yu","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7180-0190","authenticated-orcid":false,"given":"Shiou-Ru","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pi-Hui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang-Chou","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan Yung-Chih","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7062-3578","authenticated-orcid":false,"given":"Ming-Fu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.04.006_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.552909","article-title":"Comparative review of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza A respiratory viruses","volume":"11","author":"Abdelrahman","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.04.006_b0010","doi-asserted-by":"crossref","first-page":"ftaa033","DOI":"10.1093\/femspd\/ftaa033","article-title":"SARS, MERS and COVID-19: clinical manifestations and organ-system complications: a mini review","volume":"78","author":"Gerges Harb","year":"2020","journal-title":"Pathogens Disease"},{"key":"10.1016\/j.vaccine.2023.04.006_b0015","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/20477724.2015.1122852","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction","volume":"109","author":"Omrani","year":"2015","journal-title":"Pathogens Global Health"},{"key":"10.1016\/j.vaccine.2023.04.006_b0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Ann Rev Virol"},{"key":"10.1016\/j.vaccine.2023.04.006_b0025","doi-asserted-by":"crossref","first-page":"9379","DOI":"10.1128\/JVI.01277-13","article-title":"The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies","volume":"87","author":"Mou","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.04.006_b0030","doi-asserted-by":"crossref","first-page":"15214","DOI":"10.1073\/pnas.1407087111","article-title":"Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein","volume":"111","author":"Millet","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2023.04.006_b0035","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2023.04.006_b0040","doi-asserted-by":"crossref","first-page":"301ra132","DOI":"10.1126\/scitranslmed.aac7462","article-title":"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates","volume":"7","author":"Muthumani","year":"2015","journal-title":"Sci Trans Med"},{"key":"10.1016\/j.vaccine.2023.04.006_b0045","doi-asserted-by":"crossref","first-page":"e81587","DOI":"10.1371\/journal.pone.0081587","article-title":"A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines","volume":"8","author":"Du","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.04.006_b0050","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1473-3099(20)30248-6","article-title":"Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial","volume":"20","author":"Koch","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.006_b0055","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1473-3099(20)30160-2","article-title":"Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial","volume":"20","author":"Folegatti","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.006_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100689","article-title":"Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial","volume":"31","author":"Tebas","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2023.04.006_b0065","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","article-title":"Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development","volume":"31","author":"Kushnir","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.006_b0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/v11010074","article-title":"Middle East respiratory syndrome vaccine candidates: cautious optimism","volume":"11","author":"Schindewolf","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2023.04.006_b0075","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1080\/21645515.2017.1296994","article-title":"Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection","volume":"13","author":"Wang","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.04.006_b0080","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.1073\/pnas.1510199112","article-title":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus","volume":"112","author":"Corti","year":"2015","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.vaccine.2023.04.006_b0085","doi-asserted-by":"crossref","first-page":"e1000197","DOI":"10.1371\/journal.ppat.1000197","article-title":"Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway","volume":"4","author":"Sui","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2023.04.006_b0090","doi-asserted-by":"crossref","first-page":"E2018","DOI":"10.1073\/pnas.1402074111","article-title":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution","volume":"111","author":"Tang","year":"2014","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.vaccine.2023.04.006_b0095","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1371\/journal.pmed.0030237","article-title":"Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants","volume":"3","author":"ter Meulen","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2023.04.006_b0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.antiviral.2017.12.007","article-title":"A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization","volume":"150","author":"Liu","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2023.04.006_b0105","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12967-019-2116-8","article-title":"Epitope-based peptide vaccine design and target site depiction against Middle East respiratory syndrome coronavirus: an immune-informatics study","volume":"17","author":"Tahir Ul Qamar","year":"2019","journal-title":"J Transl Med"},{"key":"10.1016\/j.vaccine.2023.04.006_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.197863","article-title":"Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein","volume":"278","author":"Goo","year":"2020","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2023.04.006_b0115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1099\/vir.0.067108-0","article-title":"Thirty years of baculovirus-insect cell protein expression: from dark horse to mainstream technology","volume":"96","author":"van Oers","year":"2015","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2023.04.006_b0120","doi-asserted-by":"crossref","first-page":"13473","DOI":"10.1038\/ncomms13473","article-title":"Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines","volume":"7","author":"Du","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2023.04.006_b0125","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/cmi.2015.03","article-title":"Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus","volume":"13","author":"Zhang","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.vaccine.2023.04.006_b0130","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.vaccine.2016.03.037","article-title":"Analysis of the immunogenicity and bioactivities of a split influenza A\/H7N9 vaccine mixed with MF59 adjuvant in BALB\/c mice","volume":"34","author":"Ou","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.006_b0135","doi-asserted-by":"crossref","first-page":"29368","DOI":"10.1038\/srep29368","article-title":"Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing","volume":"6","author":"Ng","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2023.04.006_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152905","article-title":"Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review","volume":"60","author":"Lacaille-Dubois","year":"2019","journal-title":"Phytomed: Int J Phytotherapy Phytopharmacol"},{"key":"10.1016\/j.vaccine.2023.04.006_b0145","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jmb.2004.09.079","article-title":"Foldon, the natural trimerization domain of T4 fibritin, dissociates into a monomeric A-state form containing a stable beta-hairpin: atomic details of trimer dissociation and local beta-hairpin stability from residual dipolar couplings","volume":"344","author":"Meier","year":"2004","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2023.04.006_b0150","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ab.2008.04.012","article-title":"Protocol to determine accurate absorption coefficients for iron-containing transferrins","volume":"378","author":"James","year":"2008","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2023.04.006_b0155","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/infdis\/jiy574","article-title":"Elevated human dipeptidyl peptidase 4 expression reduces the susceptibility of hDPP4 transgenic mice to Middle East respiratory syndrome coronavirus infection and disease","volume":"219","author":"Algaissi","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.006_b0160","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1128\/JVI.03427-14","article-title":"Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease","volume":"89","author":"Agrawal","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.04.006_b0165","doi-asserted-by":"crossref","first-page":"15092","DOI":"10.1038\/ncomms15092","article-title":"Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains","volume":"8","author":"Yuan","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2023.04.006_b0170","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/infdis\/jiz137","article-title":"A highly immunogenic, protective, and safe adenovirus-based vaccine expressing Middle East respiratory syndrome coronavirus S1-CD40L fusion protein in a transgenic human dipeptidyl peptidase 4 mouse model","volume":"220","author":"Hashem","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.006_b0175","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1073\/pnas.1323279111","article-title":"Rapid generation of a mouse model for Middle East respiratory syndrome","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.vaccine.2023.04.006_b0180","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.diagmicrobio.2018.10.011","article-title":"MERS coronavirus outbreak: Implications for emerging viral infections","volume":"93","author":"Al-Omari","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.006_b0185","first-page":"e01651","article-title":"Recombinant receptor-binding domains of multiple Middle East respiratory syndrome coronaviruses (MERS-CoVs) induce cross-neutralizing antibodies against divergent human and camel MERS-CoVs and antibody escape mutants","volume":"91","author":"Tai","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.04.006_b0190","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.abe1502","article-title":"Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate","volume":"370","author":"Bangaru","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2023.04.006_b0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.immuni.2005.05.010","article-title":"FcgammaRIV: a novel FcR with distinct IgG subclass specificity","volume":"23","author":"Nimmerjahn","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2023.04.006_b0200","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/CVI.00156-06","article-title":"Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza","volume":"13","author":"Huber","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2023.04.006_b0205","doi-asserted-by":"crossref","first-page":"e35421","DOI":"10.1371\/journal.pone.0035421","article-title":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus","volume":"7","author":"Tseng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.04.006_b0210","doi-asserted-by":"crossref","first-page":"e02015","DOI":"10.1128\/JVI.02015-19","article-title":"Molecular mechanism for antibody-dependent enhancement of coronavirus entry","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.04.006_b0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral targets for vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2023.04.006_b0220","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fimmu.2014.00171","article-title":"T cell responses to viral infections - opportunities for peptide vaccination","volume":"5","author":"Rosendahl Huber","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.04.006_b0225","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1146\/annurev.immunol.21.120601.140942","article-title":"Molecular mechanisms regulating Th1 immune responses","volume":"21","author":"Szabo","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2023.04.006_b0230","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/vaccines9121504","article-title":"Innovations in the insect cell expression system for industrial recombinant vaccine antigen production","volume":"9","author":"Cox","year":"2021","journal-title":"Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23003900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23003900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:23:27Z","timestamp":1715127807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23003900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":46,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0264410X23003900"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subunit vaccines with a saponin-based adjuvant boost humoral and cellular immunity to MERS coronavirus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}